MA-CEAL Community Health Ambassador Program

NCT ID: NCT07136402

Last Updated: 2025-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-30

Study Completion Date

2028-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being conducted to investigate how to increase primary care health care visits and screenings and treatment for hypertension and diabetes in residents of housing developments in Boston. The investigators are partnering with Boston Housing Authority (BHA) and Trinity housing management to randomize 12 housing developments (6 in intervention and 6 in control). 6 residents from the housing developments will become Community Health Ambassadors (CHA). The CHAs will be trained to conduct "workshops" within the intervention arm. These workshops will cover Diabetes Mellitus (DM) and Hypertension (HTN) information. Along with the workshops, CHAs will act as mentors for the residents and provide them with resources to connect them to primary care, Community Health Centers, food pantry resources, how to get insurance, and other needed services. CHAs will be part-time employees of the Massachusetts Community Engaged Alliance (MA-CEAL), so they will be paid for the work they are doing while simultaneously building their professional skill set.

MA-CEAL's community engagement (CE) team will act as liaisons and mentors for the CHA's to help guide them and also connect them to opportunities for career/personal development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Diabetes Mellitus Health Care Utilization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A waitlist-control trial design will be used for this study. 6 of the 12 participating housing developments will be randomized into the intervention arm and 6 into the control arm. At month 0 all participants will participate in baseline activities (surveys). At month 18 the control arm will begin the intervention. The whole study is projected to take 36 months.
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention (Phase A)

Community health centers randomized into this arm will receive study interventions in the first 18 months of the study.

Group Type EXPERIMENTAL

Educating participants about healthcare resources

Intervention Type OTHER

MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.

Healthcare appointments

Intervention Type OTHER

MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.

Workshops

Intervention Type OTHER

Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.

Control (Phase B)

Community health centers randomized into this arm will be wait listed and will not receive study interventions during the first 18 months of the study. They will receive study interventions during the last 12 months of the study.

Group Type EXPERIMENTAL

Educating participants about healthcare resources

Intervention Type OTHER

MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.

Healthcare appointments

Intervention Type OTHER

MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.

Workshops

Intervention Type OTHER

Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educating participants about healthcare resources

MA-CEAL team members, including the community health ambassador (CHA), will assist in connecting residents with healthcare resources.

Intervention Type OTHER

Healthcare appointments

MA-CEAL team members, including the community health ambassador (CHA), will assist residents in making physician appointments.

Intervention Type OTHER

Workshops

Trained CHAs will provide workshops with information about diabetes and hypertension and how to be screened and get care.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current resident in selected Boston Health Authority (BHA) and Trinity housing developments
* Speak and understand English and/or Spanish

Exclusion Criteria

* Does not speak English or Spanish
* Not a resident of the development
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Massachusetts Community Engaged Alliance (MA-CEAL)

UNKNOWN

Sponsor Role collaborator

Boston Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin Linas, MD MPH

Role: PRINCIPAL_INVESTIGATOR

Boston Medical Center, Infectious Disease

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OT2HL158287

Identifier Type: NIH

Identifier Source: secondary_id

View Link

H-45218

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CommunityRx-Cardiovascular Disease
NCT06264726 ACTIVE_NOT_RECRUITING NA
Cancer PRevention Through Enhanced EnvironMenT
NCT06864260 ACTIVE_NOT_RECRUITING NA